Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Robert Repella


  • Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), 2019-05-23
  • Svp & Chief Commercial Officer at Vanda Pharmaceuticals Inc. (VNDA), 2013-11-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VNDA $12.12 64,100 Officer 15,000 2013-11-21 Filing
VNDA $11.89 40,515 Officer 21,490 2013-11-20 Filing
VNDA $12.07 2,885 Officer 21,490 2013-11-19 Filing